Nicotine patch "safe and well tolerated" in adolescents who smoke -- Pediatrics study.
This article was originally published in The Tan Sheet
Executive Summary
NICOTINE PATCH THERAPY IN ADOLESCENTS "SAFE AND WELL TOLERATED" in a non-randomized, open-label clinical study conducted by Todd Smith, MD, et al., Mayo Clinic. The study, published in the October issue of Pediatrics, determined that 22 mg/day nicotine patch therapy "seems safe and well tolerated in adolescent smokers" under 18. The authors noted, however, that further placebo-controlled studies are needed to demonstrate the efficacy of the patches in adolescent populations.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning